国产无码视频在线观看|做天天爱夜夜爽|AV无码专区在线|欧美乱码专区视频免费看 -亚洲欧洲免费无码-亚洲第一二三四区-欧美国产日本精品一区二区三区-国产黄色大片在线观看

Neurotropic Tyrosine Receptor Kinase (NTRK) is a type of biomarker for cancer therapy and can be found in over 25 different types of cancer. NTRK gene fusions can be detected with a number of biomarker tests including NGS (Next Generation Sequencing). This is the only way to identify people who may be eligible for therapies that target these mutations. OrigiMed has one of the clinical databases with information on gene fusion. OriFusion is a patented technique, in partnership with Bayer, to detect specific gene fusions which allows treatment with targeted therapies such as Entrectinib. Companion Diagnostics (CDx) is a testing panel that screens for hundreds of gene sequences to be compared against known matches, which then allows for other specific targeted therapies to be used.